A breast cancer diagnosis often arrives as a profound turning point, bringing uncertainty and complex emotions. While the ...

A new study has found a way to treat patients with triple-negative breast cancer using a shorter and less toxic treatment plan while achieving similar results to the current standard. The study, ...

That said, Kate has shared regular updates on her experience with cancer and treatment. She first revealed her cancer diagnosis in March 2024, sharing that she'd be undergoing chemotherapy.

Recent advances in immunotherapy have revolutionized the treatment of breast and gynecological cancers, and current ...

If you have metastatic breast cancer, you may need help from loved ones and your medical team along the way. Here’s how to ...

Several studies show that isolation is very common among those diagnosed with metastatic breast cancer. However, there are ...

The next day, Rudman realized the way to pay it forward was to give the gift of support, resources and community to anyone in Kansas City who is impacted by breast cancer. “People always say, ‘Welcome ...

A far shorter, simpler, and less toxic treatment protocol for patients with triple-negative breast cancer produced outcomes ...

A patient found to carry a BRCA1 pathogenic variant is not referred to a certified genetic counselor in her health system.

T-DM1 sustained the improvement in invasive disease-free survival over trastuzumab in HER2-positive early breast cancer.

Atossa is also announcing the issuance of a new patent on January 21, 2025, U.S. Patent No. 12,201,591, entitled, “Sustained Release Compositions of Endoxifen.” The 31 claims of this new patent are ...

Among patients with advanced PIK3CA-mutated, HR-positive/HER2-negative breast cancer, Itovebi-based treatment generated positive overall survival results.